×
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Biobanking Market Share

ID: MRFR/HC/4511-HCR
200 Pages
Rahul Gotadki
October 2025

Biobanking Market Research Report By Sample Type (Blood Products, Tissues, Cells, Nucleic Acids, Microbiome Samples), By Application (Research and Development, Clinical Trials, Personalized Medicine, Regenerative Medicine), By End-use (Academic Research Institutions, Biotechnology Companies, Pharmaceutical Companies, Government Organizations), By Storage Type (Vapor Phase Storage, Liquid Phase Storage, Cryopreservation Storage), and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Biobanking Market Infographic
Request Free Sample
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

Market Share

Biobanking Market Share Analysis

The Biobanking market assumes an essential part in the field of clinical examination by putting away and overseeing usual samples for different purposes, including clinical studies and customized medicine. As the interest for excellent natural examples develops, organizations in the biobanking area decisively position themselves to catch a critical market share. Effective biobanking organizations center around differentiating the kinds of natural samples they store. This incorporates blood, tissues, cells, and DNA samples, taking special care of the various requirements of analysts across various logical disciplines. Offering a wide scope of test types upgrades an organization's enticement for a more extensive client base. Vigorous information management frameworks and severe safety efforts are fundamental in the biobanking business. Organizations put resources into cutting edge data innovation to guarantee exact example following, effective information recovery, and consistence with security guidelines. Focusing on information security upgrades client trust and supports an organization's market position. Perceiving the interesting prerequisites of examination substances, biobanking organizations offer altered administrations. Fitting answers for scholarly examination, drug advancement, or clinical preliminaries guarantees that clients get administrations lined up with their requirements, encouraging long haul associations and reliability. Driving biobanking organizations effectively take part in instructive drives. Studios, preparing projects, and workshops assist specialists and medical services experts with figuring out the significance of legitimate example assortment, stockpiling, and utilization. Instructing the market adds to a positive industry picture and advances the reception of biobanking administrations. Progressively, biobanking organizations highlight natural maintainability rehearses. This includes embracing eco-accommodating cycles, diminishing waste, and carrying out energy-effective measures in specimen storerooms. Green drives line up with worldwide supportability objectives as well as resound emphatically with earth cognizant clients. Forceful marketing procedures add to compelling market situating. Organizations use computerized stages, industry meetings, and logical distributions to advance their skill, highlight office capacities, and lay out areas of strength for a presence. Compelling marketing improves perceivability and draws in potential clients looking for dependable biobanking administrations.

Author
Rahul Gotadki
Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Get In Touch

Leave a Comment

FAQs

What is the projected growth of the Biobanking market?

The Biobanking market is the expected increase in total market value of 117.55 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

What is the size of the Biobanking market?

Biobanking market size was valued at approximately 75.39 billion USD in 2024. This figure will reach 117.55 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

What is the CAGR of the Biobanking market?

Biobanking market is expected to grow at a CAGR of 4.12% between 2025 and 2035.

How much will the Biobanking market be worth by 2035?

Biobanking market is expected to be worth of 117.55 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

How will the Biobanking market perform over the next 10 years?

Over the next 10 years the Biobanking market is expected to shift from usd billion 75.39 to 117.55 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.

What was the market size of the Biobanking Market in 2024?

The Biobanking Market was valued at 5.14 billion USD in 2024.

What will the market size be for the European region in 2035?

The market size for Europe is projected to reach 2.1 billion USD by 2035.

What was the market size for blood products in 2024?

The market size for blood products in 2024 was 1.5 billion USD.

Who are the key players in the Biobanking Market?

Key players include Becton Dickinson, Biolife Solutions, and Thermo Fisher Scientific among others.

What is the anticipated market size for microbiome samples by 2035?

The anticipated market size for microbiome samples in 2035 is expected to be 0.2 billion USD.

Market Summary

As per MRFR analysis, the Biobanking Market Size was estimated at 75.39 USD Billion in 2024. The Biobanking industry is projected to grow from 78.5 USD Billion in 2025 to 117.55 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 4.12 during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The biobanking market is poised for substantial growth driven by technological advancements and increasing demand for personalized medicine.

  • Technological integration is transforming biobanking operations, enhancing data management and sample preservation.
  • North America remains the largest market for biobanking, while the Asia-Pacific region is emerging as the fastest-growing area.
  • The research segment dominates the market, whereas the clinical trials segment is experiencing rapid expansion.
  • Rising demand for personalized medicine and increased investment in research and development are key drivers propelling market growth.

Market Size & Forecast

2024 Market Size 75.39 (USD Billion)
2035 Market Size 117.55 (USD Billion)
CAGR (2025 - 2035) 4.12%
Largest Regional Market Share in 2024 North America

Major Players

<p>Thermo Fisher Scientific (US), Qiagen (DE), Illumina (US), Merck KGaA (DE), STEMCELL Technologies (CA), BioLife Sciences (US), Tecan Group (CH), Biosample Solutions (US), ReproCELL (JP), Asterand Bioscience (US)</p>

Market Trends

The Biobanking Market is currently experiencing a transformative phase, characterized by advancements in technology and an increasing emphasis on personalized medicine. The integration of artificial intelligence and machine learning into biobanking processes appears to enhance data analysis and sample management, thereby improving research outcomes. Furthermore, the growing awareness of the importance of biobanks in drug development and disease prevention is likely to drive investment and collaboration among various stakeholders, including academic institutions, pharmaceutical companies, and healthcare organizations. This collaborative environment fosters innovation and accelerates the translation of research findings into clinical applications, which may ultimately benefit patient care. In addition, regulatory frameworks surrounding biobanking are evolving, suggesting a more structured approach to ethical considerations and data privacy. As biobanks expand their operations globally, adherence to these regulations becomes paramount. The Biobanking Market seems poised for growth, with an increasing number of biobanks emerging to meet the rising demand for biological samples. This trend indicates a robust future for biobanking, as it plays a crucial role in advancing scientific research and improving health outcomes across diverse populations.

Technological Integration

The incorporation of advanced technologies, such as artificial intelligence and machine learning, is reshaping the Biobanking Market. These innovations facilitate enhanced data management and analysis, leading to more efficient sample processing and improved research capabilities.

Regulatory Evolution

The Biobanking Market is witnessing a shift in regulatory frameworks, which emphasizes ethical standards and data protection. This evolution suggests that biobanks must adapt to comply with new guidelines, ensuring the responsible use of biological materials.

Collaborative Research Initiatives

There is a noticeable increase in partnerships among academic institutions, pharmaceutical companies, and healthcare organizations within the Biobanking Market. These collaborations aim to leverage shared resources and expertise, ultimately accelerating research and development efforts.

Biobanking Market Market Drivers

Market Growth Projections

The Global Biobanking Market Industry is projected to experience substantial growth, with estimates indicating a market value of 5.14 USD Billion in 2024 and a potential increase to 8 USD Billion by 2035. This growth trajectory suggests a compound annual growth rate of 4.1% from 2025 to 2035. Factors contributing to this expansion include increasing demand for personalized medicine, advancements in technology, and growing investment in research and development. As the market evolves, it is likely to attract further interest from stakeholders across various sectors, including healthcare, pharmaceuticals, and biotechnology.

Regulatory Support and Standardization

Regulatory support and standardization are pivotal in shaping the Global Biobanking Market Industry. Governments are establishing frameworks to ensure ethical practices in biobanking, which enhances public trust and encourages participation. Standardization of sample collection, processing, and storage protocols is essential for maintaining data integrity and reproducibility in research. As regulatory bodies continue to refine guidelines, biobanks are better positioned to meet the demands of researchers and healthcare providers. This regulatory environment is likely to contribute to the market's growth, with projections indicating a rise to 5.14 USD Billion in 2024.

Rising Awareness of Biobanking Benefits

Rising awareness of the benefits of biobanking is driving participation and investment in the Global Biobanking Market Industry. Educational initiatives aimed at healthcare professionals and the public are highlighting the critical role biobanks play in advancing medical research and improving patient care. Increased understanding of how biobanks contribute to disease prevention, diagnosis, and treatment is likely to enhance public willingness to donate biological samples. This heightened awareness is expected to support the market's growth, with projections indicating a rise to 5.14 USD Billion in 2024 and further growth towards 8 USD Billion by 2035.

Technological Advancements in Biobanking

Technological advancements are transforming the Global Biobanking Market Industry, enabling more efficient sample management and data analysis. Innovations such as automated sample processing, advanced biorepositories, and sophisticated data analytics tools are enhancing the operational capabilities of biobanks. These technologies facilitate the integration of large datasets, allowing for more comprehensive research outcomes. As a result, biobanks can better support personalized medicine initiatives and large-scale epidemiological studies. The market's growth trajectory, with an expected value of 8 USD Billion by 2035, is indicative of the significant impact that technology has on biobanking practices.

Increasing Demand for Personalized Medicine

The Global Biobanking Market Industry is witnessing a surge in demand for personalized medicine, which relies heavily on biobanks for genetic and biological samples. This trend is driven by advancements in genomics and biotechnology, enabling tailored treatments for various diseases. For instance, biobanks facilitate the identification of genetic markers associated with specific conditions, thereby enhancing the efficacy of therapies. As the market evolves, the value is projected to reach 5.14 USD Billion in 2024, with expectations of expanding to 8 USD Billion by 2035, reflecting a compound annual growth rate of 4.1% from 2025 to 2035.

Growing Investment in Research and Development

Investment in research and development within the Global Biobanking Market Industry is on the rise, as governments and private entities recognize the importance of biobanks in advancing medical research. Funding initiatives are increasingly directed towards biobanking infrastructure, which supports the collection, storage, and analysis of biological samples. This investment not only enhances the capabilities of biobanks but also fosters collaboration between academic institutions and industry stakeholders. The anticipated growth in the market, reaching 8 USD Billion by 2035, underscores the critical role that R&D plays in driving innovation and improving healthcare outcomes.

Market Segment Insights

By Application: Research (Largest) vs. Clinical Trials (Fastest-Growing)

<p>In the Biobanking Market, the application segment showcases a diverse landscape, with research being the dominant force. Research accounts for the largest share as biobanks play a crucial role in supporting various studies and investigations, especially in genomics, proteomics, and drug development. Following closely, clinical trials emerge as a significant segment, gaining momentum due to the increasing demand for personalized medicine and advancements in biotechnology that require extensive data collection and sample analysis. Moreover, the growth trends within this segment indicate a strong upward trajectory, particularly for clinical trials, which are adopting innovative methodologies and technologies to enhance patient recruitment and data management. Regenerative medicine and pharmaceutical development are also on the rise, driven by the necessity for new therapies and treatments emerging from ongoing research. The convergence of these applications indicates a robust future for biobanking, catering to evolving healthcare needs and scientific inquiries.</p>

<p>Research (Dominant) vs. Regenerative Medicine (Emerging)</p>

<p>The research area within the Biobanking Market holds a dominant position, primarily driven by its foundational role in scientific inquiry and medical advancements. It encompasses various disciplines, from genomics to drug discovery, legitimizing the necessity of biobanks in storing and providing critical biological samples for long-term studies. On the other hand, regenerative medicine is marked as an emerging segment, characterized by its innovative approaches to heal or replace damaged tissues and organs. This sector is experiencing growth through increased funding and interest in stem cell research and cellular therapies. While research continues to be the backbone of biobanking, regenerative medicine signals exciting new possibilities, fostering collaborations between biobanks and therapeutic developers.</p>

By Sample Type: Blood (Largest) vs. Tissue (Fastest-Growing)

<p>In the Biobanking Market, blood samples hold the largest market share, driven by their critical role in various medical and research applications such as diagnostics, therapeutic monitoring, and disease prevention. Tissue samples, while currently smaller in market share, are emerging as a significant contributor due to advancements in regenerative medicine and personalized therapies. The demand for diverse biological materials to support research is leading to an increase in tissue-banking initiatives, widening their application scope. The growth trends within the sample type segment are influenced by technological advancements and an increase in research activities. Blood samples are well-established and continue to dominate due to their ease of collection and extensive applications. However, tissue samples are gaining traction rapidly as innovations in sample preservation and analysis techniques enhance their utilization. The rising number of clinical trials and research studies focusing on tissue-based therapies significantly contributes to the robust growth of this segment.</p>

<p>Blood (Dominant) vs. Tissue (Emerging)</p>

<p>Blood samples are undeniably the dominant player in the Biobanking Market, primarily due to their ease of accessibility and extensive use across various research fields, including genomics and immunology. They contribute significantly to studies related to disease mechanisms and treatment outcomes. On the other hand, tissue samples represent an emerging segment with substantial growth potential driven by breakthroughs in regenerative medicine and personalized treatments. The complexity of processing and storage of tissue samples poses challenges; however, advancements in bioprocessing technology are transforming their viability in research. As both segments continue to evolve, the interplay between blood and tissue samples is expected to fuel innovations, enhancing their market relevance and application.</p>

By Storage Type: Cryopreservation (Largest) vs. Liquid Nitrogen Storage (Fastest-Growing)

<p>In the Biobanking Market, Cryopreservation stands out as the largest storage type segment, reflecting a significant portion of the market share. This storage method is favored for its efficiency and ability to maintain the integrity of biological samples over an extended period. Liquid Nitrogen Storage, while not as dominant, has been rapidly gaining traction due to its advanced preservation capabilities and cost-effectiveness, appealing to biobanks with diverse storage needs.</p>

<p>Cryopreservation: Largest vs. Ambient Storage: Emerging</p>

<p>Cryopreservation remains the dominant storage method in the biobanking sector, primarily due to its reliability and precision in preserving biological materials such as cells and tissues. It utilizes sub-zero temperatures to halt biological activity, thereby preventing degradation. In contrast, Ambient Storage is an emerging option that offers more flexibility and accessibility, particularly useful for samples that do not require freezing. While Cryopreservation is preferred by established biobanks, the rise in Ambient Storage capabilities presents a growing segment aimed at meeting variable preservation demands.</p>

By End User: Academic Institutions (Largest) vs. Pharmaceutical Companies (Fastest-Growing)

<p>The Biobanking Market is characterized by a diverse array of end users, with Academic Institutions holding the largest share due to their foundational role in research and development. These institutions utilize biobanks for research on genetic diseases, drug development, and various clinical studies, which contributes significantly to the market's stability. Following closely are Pharmaceutical Companies, which have increasingly turned to biobanks to access diverse biological specimens and data necessary for drug discovery and clinical trials, reflecting their crucial role in the market.</p>

<p>Biotechnology Companies (Dominant) vs. Hospitals (Emerging)</p>

<p>Biotechnology Companies represent a dominant force in the Biobanking Market, leveraging biobanks to acquire biological samples for innovative research and development of therapies. Their ability to bridge the gap between laboratory research and clinical application empowers them to effectively translate discoveries into marketable products. On the other hand, Hospitals are emerging players in this space, utilizing biobanks to enhance personalized medicine initiatives and improve patient care. As they increasingly recognize the value of stored biological samples for patient-specific treatments, their market influence is expected to grow, fostering collaborations with biobanks to access critical medical data and specimens.</p>

Get more detailed insights about Biobanking Market Research Report-Forecast to 2035

Regional Insights

North America : Market Leader in Biobanking

North America is poised to maintain its leadership in the biobanking market, holding a significant 40.0% share as of 2024. The region's growth is driven by increasing investments in healthcare research, advancements in biobanking technologies, and supportive regulatory frameworks. The demand for personalized medicine and regenerative therapies further fuels this growth, as institutions seek to enhance their biobanking capabilities to support innovative research initiatives. The competitive landscape in North America is robust, featuring key players such as Thermo Fisher Scientific, Illumina, and BioLife Sciences. The U.S. stands out as a major contributor, with numerous biobanks established across various states. The presence of leading research institutions and universities enhances collaboration opportunities, driving innovation and expanding the market. As the region continues to invest in biobanking infrastructure, it is expected to solidify its position as a global leader.

Europe : Emerging Biobanking Hub

Europe is emerging as a significant player in the biobanking market, with a market share of 25.0% as of 2024. The region benefits from strong governmental support and regulatory frameworks that promote biobanking initiatives. Increasing collaborations between academic institutions and biobanks, along with rising public awareness about the importance of biobanking in research, are key drivers of growth. The focus on personalized medicine and genetic research is also propelling demand for biobanking services across Europe. Leading countries in Europe include Germany, the UK, and France, which host numerous biobanks and research facilities. Key players such as Qiagen and Merck KGaA are instrumental in driving innovation and expanding service offerings. The competitive landscape is characterized by a mix of established companies and emerging startups, fostering a dynamic environment for growth. As Europe continues to enhance its biobanking capabilities, it is set to play a crucial role in global health research.

Asia-Pacific : Growing Biobanking Potential

The Asia-Pacific region is witnessing a gradual rise in the biobanking market, currently holding an 8.0% share as of 2024. This growth is primarily driven by increasing investments in healthcare infrastructure, rising awareness of biobanking's role in research, and government initiatives aimed at enhancing biobanking capabilities. The demand for biobanks is also fueled by the growing prevalence of chronic diseases and the need for personalized medicine solutions in the region. Countries like Japan, China, and Australia are leading the charge in biobanking initiatives, with significant investments from both public and private sectors. Key players such as ReproCELL and STEMCELL Technologies are expanding their presence, contributing to the competitive landscape. As the region continues to develop its biobanking infrastructure, it is expected to see substantial growth in the coming years, positioning itself as a vital player in The Biobanking.

Middle East and Africa : Emerging Market Opportunities

The Middle East and Africa region is in the nascent stages of developing its biobanking market, currently accounting for a modest 2.39% share as of 2024. The growth in this region is driven by increasing healthcare investments, rising awareness of biobanking's significance in research, and the establishment of regulatory frameworks to support biobanking initiatives. The demand for biobanks is expected to grow as healthcare systems evolve and focus on personalized medicine and research advancements. Countries such as South Africa and the UAE are leading the way in establishing biobanks, supported by government initiatives and collaborations with international organizations. The competitive landscape is still developing, with a mix of local and international players entering the market. As the region continues to invest in biobanking infrastructure, it is poised for growth, presenting opportunities for innovation and collaboration in the healthcare sector.

Key Players and Competitive Insights

The Biobanking Market is currently characterized by a dynamic competitive landscape, driven by advancements in technology, increasing demand for personalized medicine, and a growing emphasis on research and development. Key players such as Thermo Fisher Scientific (US), Qiagen (DE), and Illumina (US) are strategically positioned to leverage these trends. Thermo Fisher Scientific (US) focuses on innovation through its extensive portfolio of biobanking solutions, while Qiagen (DE) emphasizes partnerships to enhance its product offerings. Illumina (US) is heavily invested in digital transformation, aiming to streamline operations and improve data management, which collectively shapes a competitive environment that is increasingly reliant on technological advancements and strategic collaborations.

The market structure appears moderately fragmented, with numerous players vying for market share. Key business tactics include localizing manufacturing to reduce costs and optimize supply chains, which is essential in maintaining competitive pricing and ensuring product availability. The collective influence of these major players fosters a competitive atmosphere where innovation and operational efficiency are paramount.

In November 2025, Illumina (US) announced a strategic partnership with a leading healthcare provider to enhance genomic data accessibility for biobanking initiatives. This collaboration is poised to significantly improve the integration of genomic data into biobanking processes, thereby facilitating more personalized approaches to medicine. The strategic importance of this partnership lies in its potential to expand Illumina's market reach and enhance its technological capabilities in the biobanking sector.

In October 2025, Thermo Fisher Scientific (US) launched a new line of automated biobanking solutions aimed at increasing efficiency in sample processing. This move is indicative of the company's commitment to innovation and operational excellence. By automating key processes, Thermo Fisher Scientific (US) not only enhances its service offerings but also positions itself as a leader in the biobanking market, potentially attracting a broader customer base.

In September 2025, Qiagen (DE) expanded its biobanking services through the acquisition of a regional biorepository, which allows the company to enhance its service portfolio and strengthen its market presence. This acquisition is strategically significant as it enables Qiagen (DE) to offer more comprehensive solutions to its clients, thereby reinforcing its competitive position in the market.

As of December 2025, current competitive trends in the Biobanking Market include a pronounced shift towards digitalization, sustainability, and the integration of artificial intelligence (AI) in operations. Strategic alliances are increasingly shaping the landscape, as companies recognize the value of collaboration in driving innovation. The competitive differentiation is likely to evolve from traditional price-based competition to a focus on technological advancements, supply chain reliability, and innovative solutions that meet the growing demands of the market.

Key Companies in the Biobanking Market market include

Industry Developments

In an effort to increase diversity and advance personalized medicine initiatives, the U.S. National Institutes of Health (NIH) extended the All of Us Research Program in June 2025 to include the biospecimens of 500,000 more individuals.

In order to strengthen domestic sample integrity and supply, Thermo Fisher Scientific stated in May 2025 that it will invest $2 billion to modernize cold-chain and analytical facilities inside its biobanking division in North America.

With £45 million in financing, a partnership led by Genomics England and the UK Medicines and Healthcare Products Regulatory Agency (MHRA) launched Project Genome of Europe in March 2025 with the goal of accelerating pan-EU research collaborations and harmonizing cross-national biobanking standards.

In order to strengthen Asia-Pacific research capacity, AIG Hospital in southern India launched its first regional biobank in November 2024 with the goal of collecting and storing over 100,000 tissue and blood samples over the next ten years.

Initial results showing effective federated learning deployment across biobanks for multiple sclerosis research were released in October 2024 by the Clinnova effort, a cooperation between France, Germany, Switzerland, and Luxembourg, emphasizing privacy protection and interoperability.

The European biobanking network, BBMRI-ERIC, announced in April 2024 that the number of participating institutions had increased by 12%, indicating improved standardization and sample-sharing capabilities. Additionally, around 25% of biobanks in North America explored blockchain initiatives in early 2024 to safeguard data access and sample tracking processes.

Future Outlook

Biobanking Market Future Outlook

<p>The Biobanking Market is projected to grow at a 4.12% CAGR from 2024 to 2035, driven by advancements in personalized medicine, increased research funding, and technological innovations.</p>

New opportunities lie in:

  • <p>Expansion of biobanking services into emerging markets</p>
  • <p>Development of automated sample processing technologies</p>
  • <p>Partnerships with pharmaceutical companies for drug discovery initiatives</p>

<p>By 2035, the Biobanking Market is expected to be robust, driven by innovation and strategic collaborations.</p>

Market Segmentation

Biobanking Market End User Outlook

  • Academic Institutions
  • Biotechnology Companies
  • Pharmaceutical Companies
  • Hospitals

Biobanking Market Application Outlook

  • Research
  • Clinical Trials
  • Regenerative Medicine
  • Pharmaceutical Development

Biobanking Market Sample Type Outlook

  • Blood
  • Tissue
  • Cells
  • DNA
  • RNA

Biobanking Market Storage Type Outlook

  • Cryopreservation
  • Ambient Storage
  • Liquid Nitrogen Storage
  • Freezer Storage

Report Scope

MARKET SIZE 202475.39(USD Billion)
MARKET SIZE 202578.5(USD Billion)
MARKET SIZE 2035117.55(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)4.12% (2024 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
Market Forecast Period2025 - 2035
Historical Data2019 - 2024
Market Forecast UnitsUSD Billion
Key Companies ProfiledThermo Fisher Scientific (US), Qiagen (DE), Illumina (US), Merck KGaA (DE), STEMCELL Technologies (CA), BioLife Sciences (US), Tecan Group (CH), Biosample Solutions (US), ReproCELL (JP), Asterand Bioscience (US)
Segments CoveredApplication, Sample Type, Storage Type, End User
Key Market OpportunitiesIntegration of advanced genomic technologies enhances personalized medicine applications in the Biobanking Market.
Key Market DynamicsRising demand for personalized medicine drives innovation and competition in the biobanking sector.
Countries CoveredNorth America, Europe, APAC, South America, MEA

FAQs

What is the projected growth of the Biobanking market?

The Biobanking market is the expected increase in total market value of 117.55 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

What is the size of the Biobanking market?

Biobanking market size was valued at approximately 75.39 billion USD in 2024. This figure will reach 117.55 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

What is the CAGR of the Biobanking market?

Biobanking market is expected to grow at a CAGR of 4.12% between 2025 and 2035.

How much will the Biobanking market be worth by 2035?

Biobanking market is expected to be worth of 117.55 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

How will the Biobanking market perform over the next 10 years?

Over the next 10 years the Biobanking market is expected to shift from usd billion 75.39 to 117.55 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.

What was the market size of the Biobanking Market in 2024?

The Biobanking Market was valued at 5.14 billion USD in 2024.

What will the market size be for the European region in 2035?

The market size for Europe is projected to reach 2.1 billion USD by 2035.

What was the market size for blood products in 2024?

The market size for blood products in 2024 was 1.5 billion USD.

Who are the key players in the Biobanking Market?

Key players include Becton Dickinson, Biolife Solutions, and Thermo Fisher Scientific among others.

What is the anticipated market size for microbiome samples by 2035?

The anticipated market size for microbiome samples in 2035 is expected to be 0.2 billion USD.

  1. EXECUTIVE SUMMARY
    1. Market Overview
    2. Key Findings
    3. Market Segmentation
    4. Competitive Landscape
    5. Challenges and Opportunities
    6. Future Outlook
  2. MARKET INTRODUCTION
    1. Definition
    2. Scope of the study
    3. Research Objective
    4. Assumption
    5. Limitations
  3. RESEARCH METHODOLOGY
    1. Overview
    2. Data Mining
    3. Secondary Research
    4. Primary Research
    5. Primary Interviews and Information Gathering Process
    6. Breakdown of Primary Respondents
    7. Forecasting Model
    8. Market Size Estimation
    9. Bottom-Up Approach
    10. Top-Down Approach
    11. Data Triangulation
    12. Validation
  4. MARKET DYNAMICS
    1. Overview
    2. Drivers
    3. Restraints
    4. Opportunities
  5. MARKET FACTOR ANALYSIS
    1. Value chain Analysis
    2. Porter's Five Forces Analysis
    3. Bargaining Power of Suppliers
    4. Bargaining Power of Buyers
    5. Threat of New Entrants
    6. Threat of Substitutes
    7. Intensity of Rivalry
    8. COVID-19 Impact Analysis
    9. Market Impact Analysis
    10. Regional Impact
    11. Opportunity and Threat Analysis
  6. Biobanking Market, BY Sample Type (USD Billion)
    1. Blood Products
    2. Tissues
    3. Cells
    4. Nucleic Acids
    5. Microbiome Samples
  7. Biobanking Market, BY Application (USD Billion)
    1. Research and Development
    2. Clinical Trials
    3. Personalized Medicine
    4. Regenerative Medicine
  8. Biobanking Market, BY End Use (USD Billion)
    1. Academic Research Institutions
    2. Biotechnology Companies
    3. Pharmaceutical Companies
    4. Government Organizations
  9. Biobanking Market, BY Storage Type (USD Billion)
    1. Vapor Phase Storage
    2. Liquid Phase Storage
    3. Cryopreservation Storage
  10. Biobanking Market, BY Regional (USD Billion)
    1. North America
    2. US
    3. Canada
    4. Europe
    5. Germany
    6. UK
    7. France
    8. Russia
    9. Italy
    10. Spain
    11. Rest of Europe
    12. APAC
    13. China
    14. India
    15. Japan
    16. South Korea
    17. Malaysia
    18. Thailand
    19. Indonesia
    20. Rest of APAC
    21. South America
    22. Brazil
    23. Mexico
    24. Argentina
    25. Rest of South America
    26. MEA
    27. GCC Countries
    28. South Africa
    29. Rest of MEA
    30. Competitive Landscape
    31. Overview
    32. Competitive Analysis
    33. Market share Analysis
    34. Major Growth Strategy in the Biobanking Market
    35. Competitive Benchmarking
    36. Leading Players in Terms of Number of Developments in the Biobanking Market
    37. Key developments and growth strategies
    38. New Product Launch/Service Deployment
    39. Merger & Acquisitions
    40. Joint Ventures
    41. Major Players Financial Matrix
    42. Sales and Operating Income
    43. Major Players R&D Expenditure. 2023
    44. Company Profiles
    45. Novogene
    46. Financial Overview
    47. Products Offered
    48. Key Developments
    49. SWOT Analysis
    50. Key Strategies
    51. BD
    52. Financial Overview
    53. Products Offered
    54. Key Developments
    55. SWOT Analysis
    56. Key Strategies
    57. Thermo Fisher Scientific
    58. Financial Overview
    59. Products Offered
    60. Key Developments
    61. SWOT Analysis
    62. Key Strategies
    63. Global Biobank
    64. Financial Overview
    65. Products Offered
    66. Key Developments
    67. SWOT Analysis
    68. Key Strategies
    69. Oxford Biomedica
    70. Financial Overview
    71. Products Offered
    72. Key Developments
    73. SWOT Analysis
    74. Key Strategies
    75. VWR
    76. Financial Overview
    77. Products Offered
    78. Key Developments
    79. SWOT Analysis
    80. Key Strategies
    81. Biobase
    82. Financial Overview
    83. Products Offered
    84. Key Developments
    85. SWOT Analysis
    86. Key Strategies
    87. Sampled
    88. Financial Overview
    89. Products Offered
    90. Key Developments
    91. SWOT Analysis
    92. Key Strategies
    93. Celerion
    94. Financial Overview
    95. Products Offered
    96. Key Developments
    97. SWOT Analysis
    98. Key Strategies
    99. Qiagen
    100. Financial Overview
    101. Products Offered
    102. Key Developments
    103. SWOT Analysis
    104. Key Strategies
    105. MilliporeSigma
    106. Financial Overview
    107. Products Offered
    108. Key Developments
    109. SWOT Analysis
    110. Key Strategies
    111. Libra Bioscience
    112. Financial Overview
    113. Products Offered
    114. Key Developments
    115. SWOT Analysis
    116. Key Strategies
    117. STEMCELL Technologies
    118. Financial Overview
    119. Products Offered
    120. Key Developments
    121. SWOT Analysis
    122. Key Strategies
    123. Beckman Coulter
    124. Financial Overview
    125. Products Offered
    126. Key Developments
    127. SWOT Analysis
    128. Key Strategies
    129. Tecan
    130. Financial Overview
    131. Products Offered
    132. Key Developments
    133. SWOT Analysis
    134. Key Strategies
    135. Appendix
    136. References
    137. Related Reports
    138. LIST Of tables
  11. LIST OF ASSUMPTIONS
  12. North America Biobanking Market SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2035 (USD Billions)
  13. North America Biobanking Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)
  14. North America Biobanking Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)
  15. North America Biobanking Market SIZE ESTIMATES & FORECAST, BY STORAGE TYPE, 2019-2035 (USD Billions)
  16. North America Biobanking Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)
  17. US Biobanking Market SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2035 (USD Billions)
  18. US Biobanking Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)
  19. US Biobanking Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)
  20. US Biobanking Market SIZE ESTIMATES & FORECAST, BY STORAGE TYPE, 2019-2035 (USD Billions)
  21. US Biobanking Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)
  22. Canada Biobanking Market SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2035 (USD Billions)
  23. Canada Biobanking Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)
  24. Canada Biobanking Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)
  25. Canada Biobanking Market SIZE ESTIMATES & FORECAST, BY STORAGE TYPE, 2019-2035 (USD Billions)
  26. Canada Biobanking Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)
  27. Europe Biobanking Market SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2035 (USD Billions)
  28. Europe Biobanking Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)
  29. Europe Biobanking Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)
  30. Europe Biobanking Market SIZE ESTIMATES & FORECAST, BY STORAGE TYPE, 2019-2035 (USD Billions)
  31. Europe Biobanking Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)
  32. Germany Biobanking Market SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2035 (USD Billions)
  33. Germany Biobanking Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)
  34. Germany Biobanking Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)
  35. Germany Biobanking Market SIZE ESTIMATES & FORECAST, BY STORAGE TYPE, 2019-2035 (USD Billions)
  36. Germany Biobanking Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)
  37. UK Biobanking Market SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2035 (USD Billions)
  38. UK Biobanking Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)
  39. UK Biobanking Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)
  40. UK Biobanking Market SIZE ESTIMATES & FORECAST, BY STORAGE TYPE, 2019-2035 (USD Billions)
  41. UK Biobanking Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)
  42. France Biobanking Market SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2035 (USD Billions)
  43. France Biobanking Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)
  44. France Biobanking Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)
  45. France Biobanking Market SIZE ESTIMATES & FORECAST, BY STORAGE TYPE, 2019-2035 (USD Billions)
  46. France Biobanking Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)
  47. Russia Biobanking Market SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2035 (USD Billions)
  48. Russia Biobanking Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)
  49. Russia Biobanking Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)
  50. Russia Biobanking Market SIZE ESTIMATES & FORECAST, BY STORAGE TYPE, 2019-2035 (USD Billions)
  51. Russia Biobanking Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)
  52. Italy Biobanking Market SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2035 (USD Billions)
  53. Italy Biobanking Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)
  54. Italy Biobanking Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)
  55. Italy Biobanking Market SIZE ESTIMATES & FORECAST, BY STORAGE TYPE, 2019-2035 (USD Billions)
  56. Italy Biobanking Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)
  57. Spain Biobanking Market SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2035 (USD Billions)
  58. Spain Biobanking Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)
  59. Spain Biobanking Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)
  60. Spain Biobanking Market SIZE ESTIMATES & FORECAST, BY STORAGE TYPE, 2019-2035 (USD Billions)
  61. Spain Biobanking Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)
  62. Rest of Europe Biobanking Market SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2035 (USD Billions)
  63. Rest of Europe Biobanking Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)
  64. Rest of Europe Biobanking Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)
  65. Rest of Europe Biobanking Market SIZE ESTIMATES & FORECAST, BY STORAGE TYPE, 2019-2035 (USD Billions)
  66. Rest of Europe Biobanking Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)
  67. APAC Biobanking Market SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2035 (USD Billions)
  68. APAC Biobanking Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)
  69. APAC Biobanking Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)
  70. APAC Biobanking Market SIZE ESTIMATES & FORECAST, BY STORAGE TYPE, 2019-2035 (USD Billions)
  71. APAC Biobanking Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)
  72. China Biobanking Market SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2035 (USD Billions)
  73. China Biobanking Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)
  74. China Biobanking Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)
  75. China Biobanking Market SIZE ESTIMATES & FORECAST, BY STORAGE TYPE, 2019-2035 (USD Billions)
  76. China Biobanking Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)
  77. India Biobanking Market SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2035 (USD Billions)
  78. India Biobanking Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)
  79. India Biobanking Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)
  80. India Biobanking Market SIZE ESTIMATES & FORECAST, BY STORAGE TYPE, 2019-2035 (USD Billions)
  81. India Biobanking Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)
  82. Japan Biobanking Market SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2035 (USD Billions)
  83. Japan Biobanking Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)
  84. Japan Biobanking Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)
  85. Japan Biobanking Market SIZE ESTIMATES & FORECAST, BY STORAGE TYPE, 2019-2035 (USD Billions)
  86. Japan Biobanking Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)
  87. South Korea Biobanking Market SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2035 (USD Billions)
  88. South Korea Biobanking Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)
  89. South Korea Biobanking Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)
  90. South Korea Biobanking Market SIZE ESTIMATES & FORECAST, BY STORAGE TYPE, 2019-2035 (USD Billions)
  91. South Korea Biobanking Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)
  92. Malaysia Biobanking Market SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2035 (USD Billions)
  93. Malaysia Biobanking Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)
  94. Malaysia Biobanking Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)
  95. Malaysia Biobanking Market SIZE ESTIMATES & FORECAST, BY STORAGE TYPE, 2019-2035 (USD Billions)
  96. Malaysia Biobanking Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)
  97. Thailand Biobanking Market SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2035 (USD Billions)
  98. Thailand Biobanking Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)
  99. Thailand Biobanking Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)
  100. Thailand Biobanking Market SIZE ESTIMATES & FORECAST, BY STORAGE TYPE, 2019-2035 (USD Billions)
  101. Thailand Biobanking Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)
  102. Indonesia Biobanking Market SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2035 (USD Billions)
  103. Indonesia Biobanking Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)
  104. Indonesia Biobanking Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)
  105. Indonesia Biobanking Market SIZE ESTIMATES & FORECAST, BY STORAGE TYPE, 2019-2035 (USD Billions)
  106. Indonesia Biobanking Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)
  107. Rest of APAC Biobanking Market SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2035 (USD Billions)
  108. Rest of APAC Biobanking Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)
  109. Rest of APAC Biobanking Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)
  110. Rest of APAC Biobanking Market SIZE ESTIMATES & FORECAST, BY STORAGE TYPE, 2019-2035 (USD Billions)
  111. Rest of APAC Biobanking Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)
  112. South America Biobanking Market SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2035 (USD Billions)
  113. South America Biobanking Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)
  114. South America Biobanking Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)
  115. South America Biobanking Market SIZE ESTIMATES & FORECAST, BY STORAGE TYPE, 2019-2035 (USD Billions)
  116. South America Biobanking Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)
  117. Brazil Biobanking Market SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2035 (USD Billions)
  118. Brazil Biobanking Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)
  119. Brazil Biobanking Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)
  120. Brazil Biobanking Market SIZE ESTIMATES & FORECAST, BY STORAGE TYPE, 2019-2035 (USD Billions)
  121. Brazil Biobanking Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)
  122. Mexico Biobanking Market SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2035 (USD Billions)
  123. Mexico Biobanking Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)
  124. Mexico Biobanking Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)
  125. Mexico Biobanking Market SIZE ESTIMATES & FORECAST, BY STORAGE TYPE, 2019-2035 (USD Billions)
  126. Mexico Biobanking Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)
  127. Argentina Biobanking Market SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2035 (USD Billions)
  128. Argentina Biobanking Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)
  129. Argentina Biobanking Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)
  130. Argentina Biobanking Market SIZE ESTIMATES & FORECAST, BY STORAGE TYPE, 2019-2035 (USD Billions)
  131. Argentina Biobanking Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)
  132. Rest of South America Biobanking Market SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2035 (USD Billions)
  133. Rest of South America Biobanking Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)
  134. Rest of South America Biobanking Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)
  135. Rest of South America Biobanking Market SIZE ESTIMATES & FORECAST, BY STORAGE TYPE, 2019-2035 (USD Billions)
  136. Rest of South America Biobanking Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)
  137. MEA Biobanking Market SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2035 (USD Billions)
  138. MEA Biobanking Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)
  139. MEA Biobanking Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)
  140. MEA Biobanking Market SIZE ESTIMATES & FORECAST, BY STORAGE TYPE, 2019-2035 (USD Billions)
  141. MEA Biobanking Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)
  142. GCC Countries Biobanking Market SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2035 (USD Billions)
  143. GCC Countries Biobanking Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)
  144. GCC Countries Biobanking Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)
  145. GCC Countries Biobanking Market SIZE ESTIMATES & FORECAST, BY STORAGE TYPE, 2019-2035 (USD Billions)
  146. GCC Countries Biobanking Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)
  147. South Africa Biobanking Market SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2035 (USD Billions)
  148. South Africa Biobanking Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)
  149. South Africa Biobanking Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)
  150. South Africa Biobanking Market SIZE ESTIMATES & FORECAST, BY STORAGE TYPE, 2019-2035 (USD Billions)
  151. South Africa Biobanking Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)
  152. Rest of MEA Biobanking Market SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2035 (USD Billions)
  153. Rest of MEA Biobanking Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)
  154. Rest of MEA Biobanking Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)
  155. Rest of MEA Biobanking Market SIZE ESTIMATES & FORECAST, BY STORAGE TYPE, 2019-2035 (USD Billions)
  156. Rest of MEA Biobanking Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)
    1. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    2. ACQUISITION/PARTNERSHIP
    3. LIST Of figures
  157. MARKET SYNOPSIS
  158. NORTH AMERICA BIOBANKING MARKET ANALYSIS
    1. US BIOBANKING MARKET ANALYSIS BY SAMPLE TYPE
    2. US BIOBANKING MARKET ANALYSIS BY APPLICATION
    3. US BIOBANKING MARKET ANALYSIS BY END USE
    4. US BIOBANKING MARKET ANALYSIS BY STORAGE TYPE
    5. US BIOBANKING MARKET ANALYSIS BY REGIONAL
    6. CANADA BIOBANKING MARKET ANALYSIS BY SAMPLE TYPE
    7. CANADA BIOBANKING MARKET ANALYSIS BY APPLICATION
    8. CANADA BIOBANKING MARKET ANALYSIS BY END USE
    9. CANADA BIOBANKING MARKET ANALYSIS BY STORAGE TYPE
    10. CANADA BIOBANKING MARKET ANALYSIS BY REGIONAL
  159. EUROPE BIOBANKING MARKET ANALYSIS
    1. GERMANY BIOBANKING MARKET ANALYSIS BY SAMPLE TYPE
    2. GERMANY BIOBANKING MARKET ANALYSIS BY APPLICATION
    3. GERMANY BIOBANKING MARKET ANALYSIS BY END USE
    4. GERMANY BIOBANKING MARKET ANALYSIS BY STORAGE TYPE
    5. GERMANY BIOBANKING MARKET ANALYSIS BY REGIONAL
    6. UK BIOBANKING MARKET ANALYSIS BY SAMPLE TYPE
    7. UK BIOBANKING MARKET ANALYSIS BY APPLICATION
    8. UK BIOBANKING MARKET ANALYSIS BY END USE
    9. UK BIOBANKING MARKET ANALYSIS BY STORAGE TYPE
    10. UK BIOBANKING MARKET ANALYSIS BY REGIONAL
    11. FRANCE BIOBANKING MARKET ANALYSIS BY SAMPLE TYPE
    12. FRANCE BIOBANKING MARKET ANALYSIS BY APPLICATION
    13. FRANCE BIOBANKING MARKET ANALYSIS BY END USE
    14. FRANCE BIOBANKING MARKET ANALYSIS BY STORAGE TYPE
    15. FRANCE BIOBANKING MARKET ANALYSIS BY REGIONAL
    16. RUSSIA BIOBANKING MARKET ANALYSIS BY SAMPLE TYPE
    17. RUSSIA BIOBANKING MARKET ANALYSIS BY APPLICATION
    18. RUSSIA BIOBANKING MARKET ANALYSIS BY END USE
    19. RUSSIA BIOBANKING MARKET ANALYSIS BY STORAGE TYPE
    20. RUSSIA BIOBANKING MARKET ANALYSIS BY REGIONAL
    21. ITALY BIOBANKING MARKET ANALYSIS BY SAMPLE TYPE
    22. ITALY BIOBANKING MARKET ANALYSIS BY APPLICATION
    23. ITALY BIOBANKING MARKET ANALYSIS BY END USE
    24. ITALY BIOBANKING MARKET ANALYSIS BY STORAGE TYPE
    25. ITALY BIOBANKING MARKET ANALYSIS BY REGIONAL
    26. SPAIN BIOBANKING MARKET ANALYSIS BY SAMPLE TYPE
    27. SPAIN BIOBANKING MARKET ANALYSIS BY APPLICATION
    28. SPAIN BIOBANKING MARKET ANALYSIS BY END USE
    29. SPAIN BIOBANKING MARKET ANALYSIS BY STORAGE TYPE
    30. SPAIN BIOBANKING MARKET ANALYSIS BY REGIONAL
    31. REST OF EUROPE BIOBANKING MARKET ANALYSIS BY SAMPLE TYPE
    32. REST OF EUROPE BIOBANKING MARKET ANALYSIS BY APPLICATION
    33. REST OF EUROPE BIOBANKING MARKET ANALYSIS BY END USE
    34. REST OF EUROPE BIOBANKING MARKET ANALYSIS BY STORAGE TYPE
    35. REST OF EUROPE BIOBANKING MARKET ANALYSIS BY REGIONAL
  160. APAC BIOBANKING MARKET ANALYSIS
    1. CHINA BIOBANKING MARKET ANALYSIS BY SAMPLE TYPE
    2. CHINA BIOBANKING MARKET ANALYSIS BY APPLICATION
    3. CHINA BIOBANKING MARKET ANALYSIS BY END USE
    4. CHINA BIOBANKING MARKET ANALYSIS BY STORAGE TYPE
    5. CHINA BIOBANKING MARKET ANALYSIS BY REGIONAL
    6. INDIA BIOBANKING MARKET ANALYSIS BY SAMPLE TYPE
    7. INDIA BIOBANKING MARKET ANALYSIS BY APPLICATION
    8. INDIA BIOBANKING MARKET ANALYSIS BY END USE
    9. INDIA BIOBANKING MARKET ANALYSIS BY STORAGE TYPE
    10. INDIA BIOBANKING MARKET ANALYSIS BY REGIONAL
    11. JAPAN BIOBANKING MARKET ANALYSIS BY SAMPLE TYPE
    12. JAPAN BIOBANKING MARKET ANALYSIS BY APPLICATION
    13. JAPAN BIOBANKING MARKET ANALYSIS BY END USE
    14. JAPAN BIOBANKING MARKET ANALYSIS BY STORAGE TYPE
    15. JAPAN BIOBANKING MARKET ANALYSIS BY REGIONAL
    16. SOUTH KOREA BIOBANKING MARKET ANALYSIS BY SAMPLE TYPE
    17. SOUTH KOREA BIOBANKING MARKET ANALYSIS BY APPLICATION
    18. SOUTH KOREA BIOBANKING MARKET ANALYSIS BY END USE
    19. SOUTH KOREA BIOBANKING MARKET ANALYSIS BY STORAGE TYPE
    20. SOUTH KOREA BIOBANKING MARKET ANALYSIS BY REGIONAL
    21. MALAYSIA BIOBANKING MARKET ANALYSIS BY SAMPLE TYPE
    22. MALAYSIA BIOBANKING MARKET ANALYSIS BY APPLICATION
    23. MALAYSIA BIOBANKING MARKET ANALYSIS BY END USE
    24. MALAYSIA BIOBANKING MARKET ANALYSIS BY STORAGE TYPE
    25. MALAYSIA BIOBANKING MARKET ANALYSIS BY REGIONAL
    26. THAILAND BIOBANKING MARKET ANALYSIS BY SAMPLE TYPE
    27. THAILAND BIOBANKING MARKET ANALYSIS BY APPLICATION
    28. THAILAND BIOBANKING MARKET ANALYSIS BY END USE
    29. THAILAND BIOBANKING MARKET ANALYSIS BY STORAGE TYPE
    30. THAILAND BIOBANKING MARKET ANALYSIS BY REGIONAL
    31. INDONESIA BIOBANKING MARKET ANALYSIS BY SAMPLE TYPE
    32. INDONESIA BIOBANKING MARKET ANALYSIS BY APPLICATION
    33. INDONESIA BIOBANKING MARKET ANALYSIS BY END USE
    34. INDONESIA BIOBANKING MARKET ANALYSIS BY STORAGE TYPE
    35. INDONESIA BIOBANKING MARKET ANALYSIS BY REGIONAL
    36. REST OF APAC BIOBANKING MARKET ANALYSIS BY SAMPLE TYPE
    37. REST OF APAC BIOBANKING MARKET ANALYSIS BY APPLICATION
    38. REST OF APAC BIOBANKING MARKET ANALYSIS BY END USE
    39. REST OF APAC BIOBANKING MARKET ANALYSIS BY STORAGE TYPE
    40. REST OF APAC BIOBANKING MARKET ANALYSIS BY REGIONAL
  161. SOUTH AMERICA BIOBANKING MARKET ANALYSIS
    1. BRAZIL BIOBANKING MARKET ANALYSIS BY SAMPLE TYPE
    2. BRAZIL BIOBANKING MARKET ANALYSIS BY APPLICATION
    3. BRAZIL BIOBANKING MARKET ANALYSIS BY END USE
    4. BRAZIL BIOBANKING MARKET ANALYSIS BY STORAGE TYPE
    5. BRAZIL BIOBANKING MARKET ANALYSIS BY REGIONAL
    6. MEXICO BIOBANKING MARKET ANALYSIS BY SAMPLE TYPE
    7. MEXICO BIOBANKING MARKET ANALYSIS BY APPLICATION
    8. MEXICO BIOBANKING MARKET ANALYSIS BY END USE
    9. MEXICO BIOBANKING MARKET ANALYSIS BY STORAGE TYPE
    10. MEXICO BIOBANKING MARKET ANALYSIS BY REGIONAL
    11. ARGENTINA BIOBANKING MARKET ANALYSIS BY SAMPLE TYPE
    12. ARGENTINA BIOBANKING MARKET ANALYSIS BY APPLICATION
    13. ARGENTINA BIOBANKING MARKET ANALYSIS BY END USE
    14. ARGENTINA BIOBANKING MARKET ANALYSIS BY STORAGE TYPE
    15. ARGENTINA BIOBANKING MARKET ANALYSIS BY REGIONAL
    16. REST OF SOUTH AMERICA BIOBANKING MARKET ANALYSIS BY SAMPLE TYPE
    17. REST OF SOUTH AMERICA BIOBANKING MARKET ANALYSIS BY APPLICATION
    18. REST OF SOUTH AMERICA BIOBANKING MARKET ANALYSIS BY END USE
    19. REST OF SOUTH AMERICA BIOBANKING MARKET ANALYSIS BY STORAGE TYPE
    20. REST OF SOUTH AMERICA BIOBANKING MARKET ANALYSIS BY REGIONAL
  162. MEA BIOBANKING MARKET ANALYSIS
    1. GCC COUNTRIES BIOBANKING MARKET ANALYSIS BY SAMPLE TYPE
    2. GCC COUNTRIES BIOBANKING MARKET ANALYSIS BY APPLICATION
    3. GCC COUNTRIES BIOBANKING MARKET ANALYSIS BY END USE
    4. GCC COUNTRIES BIOBANKING MARKET ANALYSIS BY STORAGE TYPE
    5. GCC COUNTRIES BIOBANKING MARKET ANALYSIS BY REGIONAL
    6. SOUTH AFRICA BIOBANKING MARKET ANALYSIS BY SAMPLE TYPE
    7. SOUTH AFRICA BIOBANKING MARKET ANALYSIS BY APPLICATION
    8. SOUTH AFRICA BIOBANKING MARKET ANALYSIS BY END USE
    9. SOUTH AFRICA BIOBANKING MARKET ANALYSIS BY STORAGE TYPE
    10. SOUTH AFRICA BIOBANKING MARKET ANALYSIS BY REGIONAL
    11. REST OF MEA BIOBANKING MARKET ANALYSIS BY SAMPLE TYPE
    12. REST OF MEA BIOBANKING MARKET ANALYSIS BY APPLICATION
    13. REST OF MEA BIOBANKING MARKET ANALYSIS BY END USE
    14. REST OF MEA BIOBANKING MARKET ANALYSIS BY STORAGE TYPE
    15. REST OF MEA BIOBANKING MARKET ANALYSIS BY REGIONAL
  163. KEY BUYING CRITERIA OF BIOBANKING MARKET
    1. RESEARCH PROCESS OF MRFR
  164. DRO ANALYSIS OF BIOBANKING MARKET
    1. DRIVERS IMPACT ANALYSIS: BIOBANKING MARKET
    2. RESTRAINTS IMPACT ANALYSIS: BIOBANKING MARKET
    3. SUPPLY / VALUE CHAIN: BIOBANKING MARKET
  165. BIOBANKING MARKET, BY SAMPLE TYPE, 2025 (% SHARE)
  166. BIOBANKING MARKET, BY SAMPLE TYPE, 2019 TO 2035 (USD Billions)
  167. BIOBANKING MARKET, BY APPLICATION, 2025 (% SHARE)
  168. BIOBANKING MARKET, BY APPLICATION, 2019 TO 2035 (USD Billions)
  169. BIOBANKING MARKET, BY END USE, 2025 (% SHARE)
  170. BIOBANKING MARKET, BY END USE, 2019 TO 2035 (USD Billions)
  171. BIOBANKING MARKET, BY STORAGE TYPE, 2025 (% SHARE)
  172. BIOBANKING MARKET, BY STORAGE TYPE, 2019 TO 2035 (USD Billions)
  173. BIOBANKING MARKET, BY REGIONAL, 2025 (% SHARE)
  174. BIOBANKING MARKET, BY REGIONAL, 2019 TO 2035 (USD Billions)
    1. BENCHMARKING OF MAJOR COMPETITORS

Biobanking Market Segmentation

Biobanking Market By Sample Type (USD Billion, 2019-2035)

Blood Products

Tissues

Cells

Nucleic Acids

Microbiome Samples

Biobanking Market By Application (USD Billion, 2019-2035)

Research and Development

Clinical Trials

Personalized Medicine

Regenerative Medicine

Biobanking Market By End Use (USD Billion, 2019-2035)

Academic Research Institutions

Biotechnology Companies

Pharmaceutical Companies

Government Organizations

Biobanking Market By Storage Type (USD Billion, 2019-2035)

Vapor Phase Storage

Liquid Phase Storage

Cryopreservation Storage

Biobanking Market By Regional (USD Billion, 2019-2035)

North America

Europe

South America

Asia Pacific

Middle East and Africa

Biobanking Market Regional Outlook (USD Billion, 2019-2035)

North America Outlook (USD Billion, 2019-2035)

North America Biobanking Market by Sample Type

Blood Products

Tissues

Cells

Nucleic Acids

Microbiome Samples

North America Biobanking Market by Application Type

Research and Development

Clinical Trials

Personalized Medicine

Regenerative Medicine

North America Biobanking Market by End Use Type

Academic Research Institutions

Biotechnology Companies

Pharmaceutical Companies

Government Organizations

North America Biobanking Market by Storage Type

Vapor Phase Storage

Liquid Phase Storage

Cryopreservation Storage

North America Biobanking Market by Regional Type

US

Canada

US Outlook (USD Billion, 2019-2035)

US Biobanking Market by Sample Type

Blood Products

Tissues

Cells

Nucleic Acids

Microbiome Samples

US Biobanking Market by Application Type

Research and Development

Clinical Trials

Personalized Medicine

Regenerative Medicine

US Biobanking Market by End Use Type

Academic Research Institutions

Biotechnology Companies

Pharmaceutical Companies

Government Organizations

US Biobanking Market by Storage Type

Vapor Phase Storage

Liquid Phase Storage

Cryopreservation Storage

CANADA Outlook (USD Billion, 2019-2035)

CANADA Biobanking Market by Sample Type

Blood Products

Tissues

Cells

Nucleic Acids

Microbiome Samples

CANADA Biobanking Market by Application Type

Research and Development

Clinical Trials

Personalized Medicine

Regenerative Medicine

CANADA Biobanking Market by End Use Type

Academic Research Institutions

Biotechnology Companies

Pharmaceutical Companies

Government Organizations

CANADA Biobanking Market by Storage Type

Vapor Phase Storage

Liquid Phase Storage

Cryopreservation Storage

Europe Outlook (USD Billion, 2019-2035)

Europe Biobanking Market by Sample Type

Blood Products

Tissues

Cells

Nucleic Acids

Microbiome Samples

Europe Biobanking Market by Application Type

Research and Development

Clinical Trials

Personalized Medicine

Regenerative Medicine

Europe Biobanking Market by End Use Type

Academic Research Institutions

Biotechnology Companies

Pharmaceutical Companies

Government Organizations

Europe Biobanking Market by Storage Type

Vapor Phase Storage

Liquid Phase Storage

Cryopreservation Storage

Europe Biobanking Market by Regional Type

Germany

UK

France

Russia

Italy

Spain

Rest of Europe

GERMANY Outlook (USD Billion, 2019-2035)

GERMANY Biobanking Market by Sample Type

Blood Products

Tissues

Cells

Nucleic Acids

Microbiome Samples

GERMANY Biobanking Market by Application Type

Research and Development

Clinical Trials

Personalized Medicine

Regenerative Medicine

GERMANY Biobanking Market by End Use Type

Academic Research Institutions

Biotechnology Companies

Pharmaceutical Companies

Government Organizations

GERMANY Biobanking Market by Storage Type

Vapor Phase Storage

Liquid Phase Storage

Cryopreservation Storage

UK Outlook (USD Billion, 2019-2035)

UK Biobanking Market by Sample Type

Blood Products

Tissues

Cells

Nucleic Acids

Microbiome Samples

UK Biobanking Market by Application Type

Research and Development

Clinical Trials

Personalized Medicine

Regenerative Medicine

UK Biobanking Market by End Use Type

Academic Research Institutions

Biotechnology Companies

Pharmaceutical Companies

Government Organizations

UK Biobanking Market by Storage Type

Vapor Phase Storage

Liquid Phase Storage

Cryopreservation Storage

FRANCE Outlook (USD Billion, 2019-2035)

FRANCE Biobanking Market by Sample Type

Blood Products

Tissues

Cells

Nucleic Acids

Microbiome Samples

FRANCE Biobanking Market by Application Type

Research and Development

Clinical Trials

Personalized Medicine

Regenerative Medicine

FRANCE Biobanking Market by End Use Type

Academic Research Institutions

Biotechnology Companies

Pharmaceutical Companies

Government Organizations

FRANCE Biobanking Market by Storage Type

Vapor Phase Storage

Liquid Phase Storage

Cryopreservation Storage

RUSSIA Outlook (USD Billion, 2019-2035)

RUSSIA Biobanking Market by Sample Type

Blood Products

Tissues

Cells

Nucleic Acids

Microbiome Samples

RUSSIA Biobanking Market by Application Type

Research and Development

Clinical Trials

Personalized Medicine

Regenerative Medicine

RUSSIA Biobanking Market by End Use Type

Academic Research Institutions

Biotechnology Companies

Pharmaceutical Companies

Government Organizations

RUSSIA Biobanking Market by Storage Type

Vapor Phase Storage

Liquid Phase Storage

Cryopreservation Storage

ITALY Outlook (USD Billion, 2019-2035)

ITALY Biobanking Market by Sample Type

Blood Products

Tissues

Cells

Nucleic Acids

Microbiome Samples

ITALY Biobanking Market by Application Type

Research and Development

Clinical Trials

Personalized Medicine

Regenerative Medicine

ITALY Biobanking Market by End Use Type

Academic Research Institutions

Biotechnology Companies

Pharmaceutical Companies

Government Organizations

ITALY Biobanking Market by Storage Type

Vapor Phase Storage

Liquid Phase Storage

Cryopreservation Storage

SPAIN Outlook (USD Billion, 2019-2035)

SPAIN Biobanking Market by Sample Type

Blood Products

Tissues

Cells

Nucleic Acids

Microbiome Samples

SPAIN Biobanking Market by Application Type

Research and Development

Clinical Trials

Personalized Medicine

Regenerative Medicine

SPAIN Biobanking Market by End Use Type

Academic Research Institutions

Biotechnology Companies

Pharmaceutical Companies

Government Organizations

SPAIN Biobanking Market by Storage Type

Vapor Phase Storage

Liquid Phase Storage

Cryopreservation Storage

REST OF EUROPE Outlook (USD Billion, 2019-2035)

REST OF EUROPE Biobanking Market by Sample Type

Blood Products

Tissues

Cells

Nucleic Acids

Microbiome Samples

REST OF EUROPE Biobanking Market by Application Type

Research and Development

Clinical Trials

Personalized Medicine

Regenerative Medicine

REST OF EUROPE Biobanking Market by End Use Type

Academic Research Institutions

Biotechnology Companies

Pharmaceutical Companies

Government Organizations

REST OF EUROPE Biobanking Market by Storage Type

Vapor Phase Storage

Liquid Phase Storage

Cryopreservation Storage

APAC Outlook (USD Billion, 2019-2035)

APAC Biobanking Market by Sample Type

Blood Products

Tissues

Cells

Nucleic Acids

Microbiome Samples

APAC Biobanking Market by Application Type

Research and Development

Clinical Trials

Personalized Medicine

Regenerative Medicine

APAC Biobanking Market by End Use Type

Academic Research Institutions

Biotechnology Companies

Pharmaceutical Companies

Government Organizations

APAC Biobanking Market by Storage Type

Vapor Phase Storage

Liquid Phase Storage

Cryopreservation Storage

APAC Biobanking Market by Regional Type

China

India

Japan

South Korea

Malaysia

Thailand

Indonesia

Rest of APAC

CHINA Outlook (USD Billion, 2019-2035)

CHINA Biobanking Market by Sample Type

Blood Products

Tissues

Cells

Nucleic Acids

Microbiome Samples

CHINA Biobanking Market by Application Type

Research and Development

Clinical Trials

Personalized Medicine

Regenerative Medicine

CHINA Biobanking Market by End Use Type

Academic Research Institutions

Biotechnology Companies

Pharmaceutical Companies

Government Organizations

CHINA Biobanking Market by Storage Type

Vapor Phase Storage

Liquid Phase Storage

Cryopreservation Storage

INDIA Outlook (USD Billion, 2019-2035)

INDIA Biobanking Market by Sample Type

Blood Products

Tissues

Cells

Nucleic Acids

Microbiome Samples

INDIA Biobanking Market by Application Type

Research and Development

Clinical Trials

Personalized Medicine

Regenerative Medicine

INDIA Biobanking Market by End Use Type

Academic Research Institutions

Biotechnology Companies

Pharmaceutical Companies

Government Organizations

INDIA Biobanking Market by Storage Type

Vapor Phase Storage

Liquid Phase Storage

Cryopreservation Storage

JAPAN Outlook (USD Billion, 2019-2035)

JAPAN Biobanking Market by Sample Type

Blood Products

Tissues

Cells

Nucleic Acids

Microbiome Samples

JAPAN Biobanking Market by Application Type

Research and Development

Clinical Trials

Personalized Medicine

Regenerative Medicine

JAPAN Biobanking Market by End Use Type

Academic Research Institutions

Biotechnology Companies

Pharmaceutical Companies

Government Organizations

JAPAN Biobanking Market by Storage Type

Vapor Phase Storage

Liquid Phase Storage

Cryopreservation Storage

SOUTH KOREA Outlook (USD Billion, 2019-2035)

SOUTH KOREA Biobanking Market by Sample Type

Blood Products

Tissues

Cells

Nucleic Acids

Microbiome Samples

SOUTH KOREA Biobanking Market by Application Type

Research and Development

Clinical Trials

Personalized Medicine

Regenerative Medicine

SOUTH KOREA Biobanking Market by End Use Type

Academic Research Institutions

Biotechnology Companies

Pharmaceutical Companies

Government Organizations

SOUTH KOREA Biobanking Market by Storage Type

Vapor Phase Storage

Liquid Phase Storage

Cryopreservation Storage

MALAYSIA Outlook (USD Billion, 2019-2035)

MALAYSIA Biobanking Market by Sample Type

Blood Products

Tissues

Cells

Nucleic Acids

Microbiome Samples

MALAYSIA Biobanking Market by Application Type

Research and Development

Clinical Trials

Personalized Medicine

Regenerative Medicine

MALAYSIA Biobanking Market by End Use Type

Academic Research Institutions

Biotechnology Companies

Pharmaceutical Companies

Government Organizations

MALAYSIA Biobanking Market by Storage Type

Vapor Phase Storage

Liquid Phase Storage

Cryopreservation Storage

THAILAND Outlook (USD Billion, 2019-2035)

THAILAND Biobanking Market by Sample Type

Blood Products

Tissues

Cells

Nucleic Acids

Microbiome Samples

THAILAND Biobanking Market by Application Type

Research and Development

Clinical Trials

Personalized Medicine

Regenerative Medicine

THAILAND Biobanking Market by End Use Type

Academic Research Institutions

Biotechnology Companies

Pharmaceutical Companies

Government Organizations

THAILAND Biobanking Market by Storage Type

Vapor Phase Storage

Liquid Phase Storage

Cryopreservation Storage

INDONESIA Outlook (USD Billion, 2019-2035)

INDONESIA Biobanking Market by Sample Type

Blood Products

Tissues

Cells

Nucleic Acids

Microbiome Samples

INDONESIA Biobanking Market by Application Type

Research and Development

Clinical Trials

Personalized Medicine

Regenerative Medicine

INDONESIA Biobanking Market by End Use Type

Academic Research Institutions

Biotechnology Companies

Pharmaceutical Companies

Government Organizations

INDONESIA Biobanking Market by Storage Type

Vapor Phase Storage

Liquid Phase Storage

Cryopreservation Storage

REST OF APAC Outlook (USD Billion, 2019-2035)

REST OF APAC Biobanking Market by Sample Type

Blood Products

Tissues

Cells

Nucleic Acids

Microbiome Samples

REST OF APAC Biobanking Market by Application Type

Research and Development

Clinical Trials

Personalized Medicine

Regenerative Medicine

REST OF APAC Biobanking Market by End Use Type

Academic Research Institutions

Biotechnology Companies

Pharmaceutical Companies

Government Organizations

REST OF APAC Biobanking Market by Storage Type

Vapor Phase Storage

Liquid Phase Storage

Cryopreservation Storage

South America Outlook (USD Billion, 2019-2035)

South America Biobanking Market by Sample Type

Blood Products

Tissues

Cells

Nucleic Acids

Microbiome Samples

South America Biobanking Market by Application Type

Research and Development

Clinical Trials

Personalized Medicine

Regenerative Medicine

South America Biobanking Market by End Use Type

Academic Research Institutions

Biotechnology Companies

Pharmaceutical Companies

Government Organizations

South America Biobanking Market by Storage Type

Vapor Phase Storage

Liquid Phase Storage

Cryopreservation Storage

South America Biobanking Market by Regional Type

Brazil

Mexico

Argentina

Rest of South America

BRAZIL Outlook (USD Billion, 2019-2035)

BRAZIL Biobanking Market by Sample Type

Blood Products

Tissues

Cells

Nucleic Acids

Microbiome Samples

BRAZIL Biobanking Market by Application Type

Research and Development

Clinical Trials

Personalized Medicine

Regenerative Medicine

BRAZIL Biobanking Market by End Use Type

Academic Research Institutions

Biotechnology Companies

Pharmaceutical Companies

Government Organizations

BRAZIL Biobanking Market by Storage Type

Vapor Phase Storage

Liquid Phase Storage

Cryopreservation Storage

MEXICO Outlook (USD Billion, 2019-2035)

MEXICO Biobanking Market by Sample Type

Blood Products

Tissues

Cells

Nucleic Acids

Microbiome Samples

MEXICO Biobanking Market by Application Type

Research and Development

Clinical Trials

Personalized Medicine

Regenerative Medicine

MEXICO Biobanking Market by End Use Type

Academic Research Institutions

Biotechnology Companies

Pharmaceutical Companies

Government Organizations

MEXICO Biobanking Market by Storage Type

Vapor Phase Storage

Liquid Phase Storage

Cryopreservation Storage

ARGENTINA Outlook (USD Billion, 2019-2035)

ARGENTINA Biobanking Market by Sample Type

Blood Products

Tissues

Cells

Nucleic Acids

Microbiome Samples

ARGENTINA Biobanking Market by Application Type

Research and Development

Clinical Trials

Personalized Medicine

Regenerative Medicine

ARGENTINA Biobanking Market by End Use Type

Academic Research Institutions

Biotechnology Companies

Pharmaceutical Companies

Government Organizations

ARGENTINA Biobanking Market by Storage Type

Vapor Phase Storage

Liquid Phase Storage

Cryopreservation Storage

REST OF SOUTH AMERICA Outlook (USD Billion, 2019-2035)

REST OF SOUTH AMERICA Biobanking Market by Sample Type

Blood Products

Tissues

Cells

Nucleic Acids

Microbiome Samples

REST OF SOUTH AMERICA Biobanking Market by Application Type

Research and Development

Clinical Trials

Personalized Medicine

Regenerative Medicine

REST OF SOUTH AMERICA Biobanking Market by End Use Type

Academic Research Institutions

Biotechnology Companies

Pharmaceutical Companies

Government Organizations

REST OF SOUTH AMERICA Biobanking Market by Storage Type

Vapor Phase Storage

Liquid Phase Storage

Cryopreservation Storage

MEA Outlook (USD Billion, 2019-2035)

MEA Biobanking Market by Sample Type

Blood Products

Tissues

Cells

Nucleic Acids

Microbiome Samples

MEA Biobanking Market by Application Type

Research and Development

Clinical Trials

Personalized Medicine

Regenerative Medicine

MEA Biobanking Market by End Use Type

Academic Research Institutions

Biotechnology Companies

Pharmaceutical Companies

Government Organizations

MEA Biobanking Market by Storage Type

Vapor Phase Storage

Liquid Phase Storage

Cryopreservation Storage

MEA Biobanking Market by Regional Type

GCC Countries

South Africa

Rest of MEA

GCC COUNTRIES Outlook (USD Billion, 2019-2035)

GCC COUNTRIES Biobanking Market by Sample Type

Blood Products

Tissues

Cells

Nucleic Acids

Microbiome Samples

GCC COUNTRIES Biobanking Market by Application Type

Research and Development

Clinical Trials

Personalized Medicine

Regenerative Medicine

GCC COUNTRIES Biobanking Market by End Use Type

Academic Research Institutions

Biotechnology Companies

Pharmaceutical Companies

Government Organizations

GCC COUNTRIES Biobanking Market by Storage Type

Vapor Phase Storage

Liquid Phase Storage

Cryopreservation Storage

SOUTH AFRICA Outlook (USD Billion, 2019-2035)

SOUTH AFRICA Biobanking Market by Sample Type

Blood Products

Tissues

Cells

Nucleic Acids

Microbiome Samples

SOUTH AFRICA Biobanking Market by Application Type

Research and Development

Clinical Trials

Personalized Medicine

Regenerative Medicine

SOUTH AFRICA Biobanking Market by End Use Type

Academic Research Institutions

Biotechnology Companies

Pharmaceutical Companies

Government Organizations

SOUTH AFRICA Biobanking Market by Storage Type

Vapor Phase Storage

Liquid Phase Storage

Cryopreservation Storage

REST OF MEA Outlook (USD Billion, 2019-2035)

REST OF MEA Biobanking Market by Sample Type

Blood Products

Tissues

Cells

Nucleic Acids

Microbiome Samples

REST OF MEA Biobanking Market by Application Type

Research and Development

Clinical Trials

Personalized Medicine

Regenerative Medicine

REST OF MEA Biobanking Market by End Use Type

Academic Research Institutions

Biotechnology Companies

Pharmaceutical Companies

Government Organizations

REST OF MEA Biobanking Market by Storage Type

Vapor Phase Storage

Liquid Phase Storage

Cryopreservation Storage

Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Related Reports

Regional Reports
Country Reports

Customer Strories

Customer Stories
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓